We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

186 hedge funds and large institutions have $2.59B invested in Sarepta Therapeutics in 2016 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 54 increasing their positions, 52 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

292% more capital invested

Capital invested by funds: $661M → $2.59B (+$1.93B)

267% more funds holding in top 10

Funds holding in top 10: 3 → 11 (+8)

158% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 24

26% more funds holding

Funds holding: 148 → 186 (+38)

4% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 52

33% less call options, than puts

Call options by funds: $524M | Put options by funds: $780M

Holders
186
Holders Change
+38
Holders Change %
+25.68%
% of All Funds
4.96%
Holding in Top 10
11
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+266.67%
% of All Funds
0.29%
New
62
Increased
54
Reduced
52
Closed
24
Calls
$524M
Puts
$780M
Net Calls
-$256M
Net Calls Change
-$90.9M

Top Buyers

Rank Fund Capital Flow
1
TCP
Tourbillon Capital Partners
New York
+$51.8M
2
JG
Jefferies Group
New York
+$49.3M
3
Millennium Management
Millennium Management
New York
+$48.7M
4
BA
BlackRock Advisors
Delaware
+$21.1M
5
RG
Redmile Group
California
+$19.4M

Top Sellers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
-$17.3M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$15.7M
3
Morgan Stanley
Morgan Stanley
New York
-$14.6M
4
CWAM
Columbia Wanger Asset Management
Illinois
-$12.2M
5
PA
Perceptive Advisors
New York
-$11.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
126
SG Americas Securities
New York
$433K +$213K +7,059 New
OC
127
Oppenheimer & Co
New York
$405K -$411K -13,611 -67%
Prudential Financial
128
Prudential Financial
New Jersey
$393K +$193K +6,390 New
BCM
129
Bluefin Capital Management
New York
$393K +$193K +6,400 New
LCG
130
Lisanti Capital Growth
New York
$332K +$163K +5,405 New
Two Sigma Advisers
131
Two Sigma Advisers
New York
$330K +$162K +5,366 New
ICM
132
IMS Capital Management
Oregon
$315K +$155K +5,132 New
BCA
133
Benchmark Capital Advisors
New York
$307K -$1.73M -57,150 -92%
AQR Capital Management
134
AQR Capital Management
Connecticut
$306K +$151K +4,981 New
Canada Life
135
Canada Life
Manitoba, Canada
$303K – – –
Teacher Retirement System of Texas
136
Teacher Retirement System of Texas
Texas
$289K -$40K -1,322 -22%
AB
137
Amalgamated Bank
New York
$278K +$137K +4,521 New
LTFS
138
Ladenburg Thalmann Financial Services
Florida
$271K -$14.8K -488 -10%
JGC
139
J. Goldman & Co
New York
$269K -$2.59M -85,800 -95%
SO
140
STRS Ohio
Ohio
$257K +$127K +4,200 New
CPA
141
Cowen Prime Advisors
New York
$246K +$121K +4,000 New
BRWA
142
B. Riley Wealth Advisors
Florida
$241K +$118K +3,910 New
Federated Hermes
143
Federated Hermes
Pennsylvania
$239K +$118K +3,887 New
WAM
144
Wolverine Asset Management
Illinois
$239K +$118K +3,900 New
LFR
145
Lehman Financial Resources
Pennsylvania
$237K +$117K +3,861 New
AIP
146
Ameritas Investment Partners
Nebraska
$227K +$112K +3,690 New
Voloridge Investment Management
147
Voloridge Investment Management
Florida
$227K +$112K +3,700 New
BNP Paribas Financial Markets
148
BNP Paribas Financial Markets
France
$217K +$57K +1,886 +114%
WEC
149
Winslow Evans & Crocker
Massachusetts
$209K +$103K +3,400 New
QSS
150
Quantitative Systematic Strategies
Florida
$202K -$241K -7,981 -71%
4 5
6
7 8

SRPT Hedge Fund Activity: Q3 2016 in Review

186 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q3 2016, worth a combined $2.59B — up 292% from $661M a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new SRPT positions and 24 closed out — a net gain of 38 holders — while 54 added to existing stakes and 52 trimmed.

The largest buyer was Tourbillon Capital Partners, opening a new position worth an estimated $51.8M. The largest seller was Group One Trading, exiting entirely with an estimated $17.3M sold.

  • 186 institutional investors held Sarepta Therapeutics (SRPT) as of Q3 2016, up from 148 in Q2 2016.
  • Funds reported $2.59B of Sarepta Therapeutics stock for Q3 2016, up 292% quarter-over-quarter.
  • 62 funds opened new Sarepta Therapeutics positions in Q3 2016 and 24 closed out, a net change of +38 holders.
  • The largest Sarepta Therapeutics buyer in Q3 2016 was Tourbillon Capital Partners, an estimated $51.8M added.
  • The largest Sarepta Therapeutics seller in Q3 2016 was Group One Trading, an estimated $17.3M sold.

Based on aggregated 13F filings for Q3 2016.